Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
PaperCitations, authors & open-access status
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 613 citations, 2021 year and green oa status.
613
Citations
2021
Year
green
OA Status